CIK 0001390478 · Non-accelerated filer<br>Smaller reporting company
SELLAS Life Sciences Group, Inc.
Sign in to watch- Ticker
- SLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 6462005278
- Business address
- 7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
- Former names
- GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
- DEF 14A Proxy Proxy Statement
- 8-K Event Results of operations
- 10-K Report Annual Report
- 8-K Event Material agreement · Agreement ended · Unregistered share sale
- 8-K Event Material agreement · Shareholder rights changed
- 8-K Event Other events
- 8-K Event Results of operations
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change
- 8-K Event Material agreement
- 8-K Event Shareholder vote results
- 8-K Event Results of operations
- DEF 14A Proxy Proxy Statement
- 8-K Event Other events
- 8-K Event Shareholder vote results
- 8-K Event Other events
- 8-K Event Material agreement · Shareholder rights changed
- 8-K Event Other events
- 8-K Event Material agreement · Shareholder rights changed · Other events
- 8-K Event Delisting notice
- 8-K Event Other events
Page 6 of 18 · 360 filings